Gastrointestinal Cancer Market Report 2026
Download Free Sample Buy Now
Gastrointestinal Cancer Market Global Report 2026 Market Report Infographic Image

Published : April 2026

Pages : 200

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Gastrointestinal Cancer Market Report 2026

Global Outlook – By Cancer Type (Colorectal Cancer, Stomach Cancer, Esophageal Cancer, Pancreatic Cancer, Liver Cancer, Other Cancer Types), By Diagnostics (Endoscopy, Biopsy, Molecular Diagnostics, Imaging, Other Diagnostics), By Treatment (Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy, Surgery, Other Treatments), By End-User (Hospitals, Oncology Centers, Research Institutes, Diagnostic Laboratories, Other End-Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
Purchase This Report Download Sample PDF
Item added to cart!

Gastrointestinal Cancer Market Overview

• Gastrointestinal Cancer market size has reached to $27.05 billion in 2025

• Expected to grow to $47.4 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%

• Growth Driver: Rising Adoption Of Targeted Therapies Is Fueling The Growth Of The Market Due To Their Precision In Attacking Cancer Cells While Minimizing Harm To Healthy Tissue

• Market Trend: Breakthrough Monoclonal Antibody Therapies With Advance Treatment Of HER2-Negative Gastric And GEJ Adenocarcinoma

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Gastrointestinal Cancer Market?

Gastrointestinal (GI) cancer refers to a group of cancers that affect the digestive system, including the esophagus, stomach, liver, pancreas, gallbladder, small intestine, colon, and rectum. These cancers develop when abnormal cells grow uncontrollably in the GI tract. The main goal of GI cancer treatment is to eliminate or control the spread of cancer, relieve symptoms, and improve quality of life.

The main types of gastrointestinal cancer are colorectal cancer, stomach cancer, esophageal cancer, pancreatic cancer, liver cancer, and others. Colorectal cancer is a malignancy of the colon or rectum, primarily driven by genetic and lifestyle factors, enabling targeted screening and treatment within gastrointestinal oncology. It is treated with various diagnostics such as endoscopy, biopsy, molecular diagnostics, imaging, and others with several treatments including chemotherapy, immunotherapy, targeted therapy, radiation therapy, surgery, and others, and is used by various end-users such as hospitals, oncology centers, research institutes, diagnostic laboratories, and others.

Gastrointestinal Cancer Market Global Report 2026 Market Report bar graph

What Is The Gastrointestinal Cancer Market Size and Share 2026?

The gastrointestinal cancer market size has grown rapidly in recent years. It will grow from $27.05 billion in 2025 to $30.33 billion in 2026 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to increasing prevalence of gastrointestinal cancers, expansion of diagnostic imaging capabilities, rising awareness of early cancer detection, growth in oncology drug development, improved access to cancer treatment facilities.

What Is The Gastrointestinal Cancer Market Growth Forecast?

The gastrointestinal cancer market size is expected to see rapid growth in the next few years. It will grow to $47.4 billion in 2030 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to increasing investments in personalized oncology, rising adoption of biomarker-based diagnostics, expansion of immuno-oncology pipelines, growing use of minimally invasive diagnostics, increasing healthcare expenditure on cancer care. Major trends in the forecast period include increasing adoption of targeted gi cancer therapies, rising use of molecular diagnostics, growing focus on immunotherapy combinations, expansion of early cancer screening programs, enhanced integration of precision medicine.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

Global Gastrointestinal Cancer Market Segmentation

1) By Cancer Type: Colorectal Cancer, Stomach Cancer, Esophageal Cancer, Pancreatic Cancer, Liver Cancer, Other Cancer Types

2) By Diagnostics: Endoscopy, Biopsy, Molecular Diagnostics, Imaging, Other Diagnostics

3) By Treatment: Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy, Surgery, Other Treatments

4) By End-User: Hospitals, Oncology Centers, Research Institutes, Diagnostic Laboratories, Other End-Users

Subsegments:

1) By Colorectal Cancer: Colon Cancer, Rectal Cancer, Recurrent Colorectal Cancer, Metastatic Colorectal Cancer

2) By Stomach Cancer: Adenocarcinoma, Gastrointestinal Stromal Tumors (GIST), Lymphoma, Carcinoid Tumors

3) By Esophageal Cancer: Adenocarcinoma, Squamous Cell Carcinoma, Small Cell Carcinoma, Other Rare Esophageal Tumors

4) By Pancreatic Cancer: Exocrine Pancreatic Cancer, Endocrine (Neuroendocrine) Pancreatic Tumors, Metastatic Pancreatic Cancer, Resectable Or Unresectable Tumors

5) By Liver Cancer: Hepatocellular Carcinoma (HCC), Intrahepatic Cholangiocarcinoma, Hepatoblastoma, Secondary (Metastatic) Liver Cancer

6) By Other Cancer Types: Small Intestine Cancer, Anal Cancer, Gallbladder Cancer, Gastrointestinal Carcinoid Tumor

What Is The Driver Of The Gastrointestinal Cancer Market?

The rising adoption of targeted therapies is expected to propel the growth of the gastrointestinal cancer market going forward. Targeted therapies are treatments that precisely block cancer cell growth by acting on specific molecular targets, reducing harm to normal, healthy cells. Targeted therapies are designed to act on specific molecular pathways or genetic mutations driving a disease, especially in cancer. Unlike traditional treatments like chemotherapy, which attack both healthy and diseased cells, targeted therapies focus on the unique characteristics of a patient's condition. Targeted therapies for gastrointestinal (GI) cancer act on specific genes or proteins that control tumor growth, enabling precise and effective treatment. This results in better outcomes with fewer side effects than conventional chemotherapy. For instance, in July 2023, according to the American Society of Gene & Cell Therapy (ASGCT), a US-based professional membership organization, and Citeline, a US-based provider of drugs and devices, at the end of quarter one (Q1) 2023, there were 247 gene therapies in Phase II, this number rose by 5% to reach 260 by the end of quarter two (Q2). Therefore, the rising adoption of targeted therapies is driving the growth of the gastrointestinal cancer industry.

Key Players In The Global Gastrointestinal Cancer Market

Major companies operating in the gastrointestinal cancer market are Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Ipsen Biopharmaceuticals Inc., Exelixis Inc., BeiGene Ltd., Boehringer Ingelheim International GmbH, Zai Lab Limited, Taiho Pharmaceutical Co. Ltd

Global Gastrointestinal Cancer Market Trends and Insights

Major companies operating in the gastrointestinal cancer market are focused on developing advanced solutions, such as monoclonal antibody treatment, to improve patient survival rates and minimize treatment-related side effects. Monoclonal antibody treatment involves using laboratory-produced antibodies that precisely identify and attach to cancer cells, assisting the immune system in targeting and eliminating them. For instance, in September 2024, Astellas Pharma Inc., a Japan-based pharmaceutical company, launched VYLOY (zolbetuximab) in combination with fluoropyrimidine- and platinum-containing chemotherapy, which received approval from the European Commission. It is a first-line treatment for adults with locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma whose tumors express claudin 18.2 (CLDN18.2). This approval makes VYLOY the first and only therapy in the European Union targeting CLDN18.2, a biomarker in about 38% of these patients, based on positive clinical trial data from the SPOTLIGHT and GLOW studies.

Need data on a specific region in this market?
Request Regional Data

What Are Latest Mergers And Acquisitions In The Gastrointestinal Cancer Market?

In February 2025, GSK plc, a UK-based pharmaceutical and biotechnology company, acquired IDRx Inc. for approximately $1.15 billion. With this acquisition, GSK aims to strengthen its immunology and infectious disease pipeline, accelerate the development of innovative therapies, and expand its capabilities in precision medicine to better address unmet medical needs. IDRx Inc. is a US-based clinical-stage biopharmaceutical company dedicated to developing precision therapeutics for the treatment of gastrointestinal stromal tumors (GIST).

Regional Outlook

North America was the largest region in the gastrointestinal cancer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Gastrointestinal Cancer Market?

The gastrointestinal cancer market consists of revenues earned by entities by providing services such as genetic counseling and testing, palliative and supportive care, nutrition and dietary support, rehabilitation services, and follow-up and survivorship programs. The market value includes the value of related goods sold by the service provider or included within the service offering. The gastrointestinal cancer market includes sales of laparoscopic instruments, robotic surgery systems, pain management medications, and monitoring tools. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Gastrointestinal Cancer Market Report 2026?

The gastrointestinal cancer market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the gastrointestinal cancer industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Gastrointestinal Cancer Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2026 $30.33 billion
Revenue Forecast In 2035 $47.4 billion
Growth Rate CAGR of 12.1% from 2026 to 2035
Base Year For Estimation 2025
Actual Estimates/Historical Data 2020-2025
Forecast Period 2026 - 2030 - 2035
Market Representation Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered Cancer Type, Diagnostics, Treatment, End-User
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Ipsen Biopharmaceuticals Inc., Exelixis Inc., BeiGene Ltd., Boehringer Ingelheim International GmbH, Zai Lab Limited, Taiho Pharmaceutical Co. Ltd
Customization ScopeRequest for Customization
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Gastrointestinal Cancer Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Gastrointestinal Cancer Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Gastrointestinal Cancer Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Gastrointestinal Cancer Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Industry 4.0 & Intelligent Manufacturing

4.1.5 Sustainability, Climate Tech & Circular Economy

4.2. Major Trends

4.2.1 Increasing Adoption Of Targeted GI Cancer Therapies

4.2.2 Rising Use Of Molecular Diagnostics

4.2.3 Growing Focus On Immunotherapy Combinations

4.2.4 Expansion Of Early Cancer Screening Programs

4.2.5 Enhanced Integration Of Precision Medicine

5. Gastrointestinal Cancer Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Oncology Centers

5.3 Diagnostic Laboratories

5.4 Research Institutes

5.5 Specialty Cancer Clinics

6. Gastrointestinal Cancer Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Gastrointestinal Cancer Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Gastrointestinal Cancer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Gastrointestinal Cancer Market Size, Comparisons And Growth Rate Analysis

7.3. Global Gastrointestinal Cancer Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Gastrointestinal Cancer Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Gastrointestinal Cancer Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Gastrointestinal Cancer Market Segmentation

9.1. Global Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Colorectal Cancer, Stomach Cancer, Esophageal Cancer, Pancreatic Cancer, Liver Cancer, Other Cancer Types

9.2. Global Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Endoscopy, Biopsy, Molecular Diagnostics, Imaging, Other Diagnostics

9.3. Global Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Chemotherapy, Immunotherapy, Targeted Therapy, Radiation Therapy, Surgery, Other Treatments

9.4. Global Gastrointestinal Cancer Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Oncology Centers, Research Institutes, Diagnostic Laboratories, Other End-Users

9.5. Global Gastrointestinal Cancer Market, Sub-Segmentation Of Colorectal Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Colon Cancer, Rectal Cancer, Recurrent Colorectal Cancer, Metastatic Colorectal Cancer

9.6. Global Gastrointestinal Cancer Market, Sub-Segmentation Of Stomach Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adenocarcinoma, Gastrointestinal Stromal Tumors (GIST), Lymphoma, Carcinoid Tumors

9.7. Global Gastrointestinal Cancer Market, Sub-Segmentation Of Esophageal Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Adenocarcinoma, Squamous Cell Carcinoma, Small Cell Carcinoma, Other Rare Esophageal Tumors

9.8. Global Gastrointestinal Cancer Market, Sub-Segmentation Of Pancreatic Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Exocrine Pancreatic Cancer, Endocrine (Neuroendocrine) Pancreatic Tumors, Metastatic Pancreatic Cancer, Resectable Or Unresectable Tumors

9.9. Global Gastrointestinal Cancer Market, Sub-Segmentation Of Liver Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hepatocellular Carcinoma (HCC), Intrahepatic Cholangiocarcinoma, Hepatoblastoma, Secondary (Metastatic) Liver Cancer

9.10. Global Gastrointestinal Cancer Market, Sub-Segmentation Of Other Cancer Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Small Intestine Cancer, Anal Cancer, Gallbladder Cancer, Gastrointestinal Carcinoid Tumor

10. Gastrointestinal Cancer Market Regional And Country Analysis

10.1. Global Gastrointestinal Cancer Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Gastrointestinal Cancer Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Gastrointestinal Cancer Market

11.1. Asia-Pacific Gastrointestinal Cancer Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Gastrointestinal Cancer Market

12.1. China Gastrointestinal Cancer Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Gastrointestinal Cancer Market

13.1. India Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Gastrointestinal Cancer Market

14.1. Japan Gastrointestinal Cancer Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

14.2. Japan Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Gastrointestinal Cancer Market

15.1. Australia Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Gastrointestinal Cancer Market

16.1. Indonesia Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Gastrointestinal Cancer Market

17.1. South Korea Gastrointestinal Cancer Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

17.2. South Korea Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Gastrointestinal Cancer Market

18.1. Taiwan Gastrointestinal Cancer Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

18.2. Taiwan Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Gastrointestinal Cancer Market

19.1. South East Asia Gastrointestinal Cancer Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

19.2. South East Asia Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Gastrointestinal Cancer Market

20.1. Western Europe Gastrointestinal Cancer Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

20.2. Western Europe Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Gastrointestinal Cancer Market

21.1. UK Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Gastrointestinal Cancer Market

22.1. Germany Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Gastrointestinal Cancer Market

23.1. France Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Gastrointestinal Cancer Market

24.1. Italy Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Gastrointestinal Cancer Market

25.1. Spain Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Gastrointestinal Cancer Market

26.1. Eastern Europe Gastrointestinal Cancer Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

26.2. Eastern Europe Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Gastrointestinal Cancer Market

27.1. Russia Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Gastrointestinal Cancer Market

28.1. North America Gastrointestinal Cancer Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

28.2. North America Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Gastrointestinal Cancer Market

29.1. USA Gastrointestinal Cancer Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

29.2. USA Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Gastrointestinal Cancer Market

30.1. Canada Gastrointestinal Cancer Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

30.2. Canada Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Gastrointestinal Cancer Market

31.1. South America Gastrointestinal Cancer Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

31.2. South America Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Gastrointestinal Cancer Market

32.1. Brazil Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Gastrointestinal Cancer Market

33.1. Middle East Gastrointestinal Cancer Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

33.2. Middle East Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Gastrointestinal Cancer Market

34.1. Africa Gastrointestinal Cancer Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

34.2. Africa Gastrointestinal Cancer Market, Segmentation By Cancer Type, Segmentation By Diagnostics, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Gastrointestinal Cancer Market Regulatory and Investment Landscape

36. Gastrointestinal Cancer Market Competitive Landscape And Company Profiles

36.1. Gastrointestinal Cancer Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Gastrointestinal Cancer Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Gastrointestinal Cancer Market Company Profiles

36.3.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Roche Holding AG Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

37. Gastrointestinal Cancer Market Other Major And Innovative Companies

Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Ipsen Biopharmaceuticals Inc., Exelixis Inc., BeiGene Ltd., Boehringer Ingelheim International GmbH, Zai Lab Limited, Taiho Pharmaceutical Co. Ltd.

38. Global Gastrointestinal Cancer Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Gastrointestinal Cancer Market

40. Gastrointestinal Cancer Market High Potential Countries, Segments and Strategies

40.1 Gastrointestinal Cancer Market In 2030 - Countries Offering Most New Opportunities

40.2 Gastrointestinal Cancer Market In 2030 - Segments Offering Most New Opportunities

40.3 Gastrointestinal Cancer Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Gastrointestinal Cancer Market, Overview Of Key Products - Product Examples
  • Table 2: Global Gastrointestinal Cancer Market Attractiveness, Factor-Wise Evaluation
  • Table 3: Global Gastrointestinal Cancer Market, Supply Chain Analysis
  • Table 4: Global Gastrointestinal Cancer Market, Major Raw Material Providers
  • Table 5: Global Gastrointestinal Cancer Market, Major Resource Providers
  • Table 6: Global Gastrointestinal Cancer Market, Major Manufacturers (Suppliers)
  • Table 7: Global Gastrointestinal Cancer Market, Major Distributors And Channel Partners
  • Table 8: Global Gastrointestinal Cancer Market, Key Technologies & Future Trends
  • Table 9: Global Gastrointestinal Cancer Market, Major Trends
  • Table 10: Global Gastrointestinal Cancer Market, Major End Users
  • Table 11: Global Gastrointestinal Cancer Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Table 12: Global Gastrointestinal Cancer Historic Market Growth, 2020-2025, $ Billion
  • Table 13: Global Gastrointestinal Cancer Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Table 14: Global Gastrointestinal Cancer Market - TAM, US$ Billion, 2025
  • Table 15: Global Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 16: Global Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 17: Global Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 18: Global Gastrointestinal Cancer Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 19: Global Gastrointestinal Cancer Market, Sub-Segmentation Of Colorectal Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 20: Global Gastrointestinal Cancer Market, Sub-Segmentation Of Stomach Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 21: Global Gastrointestinal Cancer Market, Sub-Segmentation Of Esophageal Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 22: Global Gastrointestinal Cancer Market, Sub-Segmentation Of Pancreatic Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 23: Global Gastrointestinal Cancer Market, Sub-Segmentation Of Liver Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 24: Global Gastrointestinal Cancer Market, Sub-Segmentation Of Other Cancer Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 25: Global Gastrointestinal Cancer Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 26: Global Gastrointestinal Cancer Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 27: Asia-Pacific, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 28: Asia-Pacific, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 29: Asia-Pacific, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 30: China, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 31: China, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 32: China, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 33: India, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 34: India, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 35: India, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 36: Japan, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 37: Japan, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 38: Japan, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 39: Australia, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 40: Australia, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 41: Australia, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 42: Indonesia, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 43: Indonesia, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 44: Indonesia, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 45: South Korea, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 46: South Korea, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 47: South Korea, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 48: Taiwan, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 49: Taiwan, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 50: Taiwan, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 51: South East Asia, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 52: South East Asia, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 53: South East Asia, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 54: Western Europe, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 55: Western Europe, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 56: Western Europe, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 57: UK, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 58: UK, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 59: UK, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 60: Germany, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 61: Germany, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 62: Germany, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 63: France, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 64: France, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 65: France, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 66: Italy, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 67: Italy, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 68: Italy, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 69: Spain, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 70: Spain, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 71: Spain, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 72: Eastern Europe, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 73: Eastern Europe, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 74: Eastern Europe, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 75: Russia, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 76: Russia, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 77: Russia, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 78: North America, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 79: North America, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 80: North America, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 81: USA, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 82: USA, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 83: USA, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 84: Canada, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 85: Canada, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 86: Canada, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 87: South America, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 88: South America, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 89: South America, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 90: Brazil, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 91: Brazil, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 92: Brazil, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 93: Middle East, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 94: Middle East, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 95: Middle East, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 96: Africa, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 97: Africa, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 98: Africa, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Table 99: Global Gastrointestinal Cancer Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Table 100: Global Gastrointestinal Cancer Market - Company Scoring Matrix
  • Table 101: Pfizer Inc. Financial Performance
  • Table 102: Johnson & Johnson Financial Performance
  • Table 103: Roche Holding AG Financial Performance
  • Table 104: Merck & Co. Inc. Financial Performance
  • Table 105: Bayer AG Financial Performance
  • Table 106: Global Gastrointestinal Cancer Market, Competitive Benchmarking (In USD Billions)
  • Table 107: Global Gastrointestinal Cancer Market, Competitive Dashboard
  • Table 108: Global Gastrointestinal Cancer Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Table 109: Global, Gastrointestinal Cancer Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030
  • Table 110: Global, Gastrointestinal Cancer Market Size Gain ($ Billion), Segmentation By Diagnostics, 2025 – 2030
  • Table 111: Global, Gastrointestinal Cancer Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

List Of Figures

    Figure 1: Global Gastrointestinal Cancer Market, Overview Of Key Products - Product Examples
  • Figure 2: Global Gastrointestinal Cancer Market Attractiveness, Factor-Wise Evaluation
  • Figure 3: Global Gastrointestinal Cancer Market, Supply Chain Analysis
  • Figure 4: Global Gastrointestinal Cancer Market, Major Raw Material Providers
  • Figure 5: Global Gastrointestinal Cancer Market, Major Resource Providers
  • Figure 6: Global Gastrointestinal Cancer Market, Major Manufacturers (Suppliers)
  • Figure 7: Global Gastrointestinal Cancer Market, Major Distributors And Channel Partners
  • Figure 8: Global Gastrointestinal Cancer Market, Key Technologies & Future Trends
  • Figure 9: Global Gastrointestinal Cancer Market, Major Trends
  • Figure 10: Global Gastrointestinal Cancer Market, Major End Users
  • Figure 11: Global Gastrointestinal Cancer Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis
  • Figure 12: Global Gastrointestinal Cancer Historic Market Growth, 2020-2025, $ Billion
  • Figure 13: Global Gastrointestinal Cancer Forecast Market Growth, 2025-2030F, 2035F, $ Billion
  • Figure 14: Global Gastrointestinal Cancer Market - TAM, US$ Billion, 2025
  • Figure 15: Global Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 16: Global Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 17: Global Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 18: Global Gastrointestinal Cancer Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 19: Global Gastrointestinal Cancer Market, Sub-Segmentation Of Colorectal Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 20: Global Gastrointestinal Cancer Market, Sub-Segmentation Of Stomach Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 21: Global Gastrointestinal Cancer Market, Sub-Segmentation Of Esophageal Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 22: Global Gastrointestinal Cancer Market, Sub-Segmentation Of Pancreatic Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 23: Global Gastrointestinal Cancer Market, Sub-Segmentation Of Liver Cancer, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 24: Global Gastrointestinal Cancer Market, Sub-Segmentation Of Other Cancer Types, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 25: Global Gastrointestinal Cancer Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 26: Global Gastrointestinal Cancer Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 27: Asia-Pacific, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 28: Asia-Pacific, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 29: Asia-Pacific, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 30: China, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 31: China, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 32: China, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 33: India, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 34: India, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 35: India, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 36: Japan, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 37: Japan, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 38: Japan, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 39: Australia, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 40: Australia, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 41: Australia, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 42: Indonesia, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 43: Indonesia, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 44: Indonesia, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 45: South Korea, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 46: South Korea, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 47: South Korea, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 48: Taiwan, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 49: Taiwan, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 50: Taiwan, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 51: South East Asia, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 52: South East Asia, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 53: South East Asia, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 54: Western Europe, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 55: Western Europe, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 56: Western Europe, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 57: UK, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 58: UK, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 59: UK, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 60: Germany, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 61: Germany, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 62: Germany, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 63: France, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 64: France, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 65: France, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 66: Italy, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 67: Italy, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 68: Italy, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 69: Spain, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 70: Spain, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 71: Spain, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 72: Eastern Europe, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 73: Eastern Europe, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 74: Eastern Europe, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 75: Russia, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 76: Russia, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 77: Russia, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 78: North America, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 79: North America, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 80: North America, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 81: USA, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 82: USA, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 83: USA, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 84: Canada, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 85: Canada, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 86: Canada, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 87: South America, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 88: South America, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 89: South America, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 90: Brazil, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 91: Brazil, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 92: Brazil, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 93: Middle East, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 94: Middle East, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 95: Middle East, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 96: Africa, Gastrointestinal Cancer Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 97: Africa, Gastrointestinal Cancer Market, Segmentation By Diagnostics, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 98: Africa, Gastrointestinal Cancer Market, Segmentation By Treatment, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Figure 99: Global Gastrointestinal Cancer Key Competitor Estimated Market Shares, 2024, Percentage (%)
  • Figure 100: Global Gastrointestinal Cancer Market - Company Scoring Matrix
  • Figure 101: Pfizer Inc. Financial Performance
  • Figure 102: Johnson & Johnson Financial Performance
  • Figure 103: Roche Holding AG Financial Performance
  • Figure 104: Merck & Co. Inc. Financial Performance
  • Figure 105: Bayer AG Financial Performance
  • Figure 106: Global Gastrointestinal Cancer Market, Competitive Benchmarking (In USD Billions)
  • Figure 107: Global Gastrointestinal Cancer Market, Competitive Dashboard
  • Figure 108: Global Gastrointestinal Cancer Market Size Gain ($ Billion), 2025 – 2030 By Country
  • Figure 109: Global, Gastrointestinal Cancer Market Size Gain ($ Billion), Segmentation By Cancer Type, 2025 – 2030
  • Figure 110: Global, Gastrointestinal Cancer Market Size Gain ($ Billion), Segmentation By Diagnostics, 2025 – 2030
  • Figure 111: Global, Gastrointestinal Cancer Market Size Gain ($ Billion), Segmentation By Treatment, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

Read More About Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Read More About Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

Read More About Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Read More About CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

Read More About Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Read More About 2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Read More About Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Intestine Cancer Therapeutics Market Report 2026 - Global Outlook – By Treatment Type (Immunotherapy, Chemotherapy, Other Treatments), By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy), By App...

Gastric Cancer Drugs Market Report 2026 - Global Outlook – By Type (Imatinib, Trastuzumab, Other Types), By Route of Administration (Oral, Parenteral), By End User (Hospitals, Clinics, Cancer Speciality Centers) – Market...

Colorectal Cancer Drugs Market Report 2026 - Global Outlook – By Type (Vascular Endothelial Growth Factor (VEGF) Inhibitors, Epidermal Growth Factor Receptor (EGFR) Inhibitors, Programmed Cell Death Protein 1 Or PD1 Liga...

Colorectal Cancer Molecular Diagnostics Market Report 2026 - Global Outlook – By Type (Instruments, Reagents And Kits, Services), By Technology (Polymerase Chain Reaction (PCR), Sequencing, Mass Spectrometry, Transcripti...

Gastric Cancer Diagnostic Procedure Market Report 2026 - Global Outlook – By Procedure Type (Endoscopic Procedure, Biopsy, Tissue Tests, Lab Tests, In-Vitro Diagnostic Tests, Imaging Tests, Molecular Diagnostics, Multipl...

Clinical Nutrition For Cancer Care Market Report 2026 - Global Outlook – By Type (Oral Nutrition, Parenteral Nutrition, Enteral Feeding Formulas), By Cancer Type (Head And Neck Cancer, Stomach And Gastrointestinal Cancer...

Cancer Insurance Market Report 2026 - Global Outlook – By Insurance Coverage Type (Cancer Insurance, Supplemental Cancer Insurance Riders), By Plan Structure (Individual Cancer Insurance Plans, Family Cancer Insurance Pl...

Pancreatic Cancer Drugs Market Report 2026 - Global Outlook – By Type (Pancreatic Neuroendocrine Cancer Drugs, Pancreatic Exocrine Cancer Drugs), By Drug Combination (Single, Double, Triplet, Quadruplet), By End User (Ho...

Frequently Asked Questions

The Gastrointestinal Cancer market was valued at $27.05 billion in 2025, increased to $30.33 billion in 2026, and is projected to reach $47.4 billion by 2030.

The global Gastrointestinal Cancer market is expected to grow at a CAGR of 11.8% from 2026 to 2035 to reach $47.4 billion by 2035.

Some Key Players in the Gastrointestinal Cancer market Include, Pfizer Inc., Johnson & Johnson, Roche Holding AG, Merck & Co. Inc., Bayer AG, Sanofi S.A., Bristol‑Myers Squibb Company, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Ipsen Biopharmaceuticals Inc., Exelixis Inc., BeiGene Ltd., Boehringer Ingelheim International GmbH, Zai Lab Limited, Taiho Pharmaceutical Co. Ltd .

Major trend in this market includes: Breakthrough Monoclonal Antibody Therapies With Advance Treatment Of HER2-Negative Gastric And GEJ Adenocarcinoma. For further insights on this market. request a sample here

North America was the largest region in the gastrointestinal cancer market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal cancer market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us